TY - JOUR
T1 - Synthesis of chiral phosphoantigens and their activity in γδ T cell stimulation
AU - Song, Yongcheng
AU - Zhang, Yonghui
AU - Wang, Hong
AU - Raker, Amy
AU - Sanders, John
AU - Broderick, Erin
AU - Clark, Allen
AU - Morita, Craig
AU - Oldfield, Eric
N1 - Funding Information:
This work was supported by the US National Institutes of Health (grants GM-65307 to E.O. and AR-045504 to C.T.M.). J.M.S. is an American Heart Association, Midwest Affiliate, Predoctoral Fellow.
PY - 2004/9/6
Y1 - 2004/9/6
N2 - γδ T cells expressing Vγ2Vδ2 T cell receptors are activated by a broad range of phosphorus-containing small molecules, termed phosphoantigens, and are of interest in the context of the chemotherapy of B cell malignancies. Here, we report the synthesis of four pairs of chiral phosphoantigens: the bromohydrins of isopentenyl diphosphate (Phosphostim™), the epoxides of isopentenyl diphosphate (EIPP); and the corresponding bromohydrin and epoxide analogs of but-3-enyl diphosphate. The ability of each compound to stimulate human Vγ2Vδ2 T cells was determined by TNF-α release and cell proliferation. In these assays, the (R)-bromohydrin diphosphates were, on average, about twice as active as the (S)-bromohydrin diphosphates. In contrast, the (S)-form of EIPP was about twice as active as (R)-EIPP. The activities of the epoxy but-3-enyl diphosphates were both very low. These results suggest that chiral phosphoantigens, as opposed to racemic mixtures, may have utility in immunotherapy.
AB - γδ T cells expressing Vγ2Vδ2 T cell receptors are activated by a broad range of phosphorus-containing small molecules, termed phosphoantigens, and are of interest in the context of the chemotherapy of B cell malignancies. Here, we report the synthesis of four pairs of chiral phosphoantigens: the bromohydrins of isopentenyl diphosphate (Phosphostim™), the epoxides of isopentenyl diphosphate (EIPP); and the corresponding bromohydrin and epoxide analogs of but-3-enyl diphosphate. The ability of each compound to stimulate human Vγ2Vδ2 T cells was determined by TNF-α release and cell proliferation. In these assays, the (R)-bromohydrin diphosphates were, on average, about twice as active as the (S)-bromohydrin diphosphates. In contrast, the (S)-form of EIPP was about twice as active as (R)-EIPP. The activities of the epoxy but-3-enyl diphosphates were both very low. These results suggest that chiral phosphoantigens, as opposed to racemic mixtures, may have utility in immunotherapy.
UR - http://www.scopus.com/inward/record.url?scp=4043093435&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=4043093435&partnerID=8YFLogxK
U2 - 10.1016/j.bmcl.2004.06.052
DO - 10.1016/j.bmcl.2004.06.052
M3 - Article
C2 - 15357974
AN - SCOPUS:4043093435
SN - 0960-894X
VL - 14
SP - 4471
EP - 4477
JO - Bioorganic and Medicinal Chemistry Letters
JF - Bioorganic and Medicinal Chemistry Letters
IS - 17
ER -